• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物活性脂质 S1P 和 C1P 是人横纹肌肉瘤中的促转移因子,其组织水平会因放射/化疗而升高。

Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy.

机构信息

Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, 500 S. Floyd Street, Louisville, KY 40202, USA.

出版信息

Mol Cancer Res. 2013 Jul;11(7):793-807. doi: 10.1158/1541-7786.MCR-12-0600. Epub 2013 Apr 24.

DOI:10.1158/1541-7786.MCR-12-0600
PMID:23615526
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3720846/
Abstract

Evidence suggests that bioactive lipids may regulate pathophysiologic functions such as cancer cell metastasis. Therefore, we determined that the bioactive lipid chemoattractants sphingosine-1-phosphate (S1P) and ceramide-1-phosphate (C1P) strongly enhanced the in vitro motility and adhesion of human rhabdomyosarcoma (RMS) cells. Importantly, this effect was observed at physiologic concentrations for both bioactive lipids, which are present in biologic fluids, and were much stronger than the effects observed in response to known RMS prometastatic factors such as stromal derived factors-1 (SDF-1/CXCL12) or hepatocyte growth factor/scatter factor (HGF/SF). We also present novel evidence that the levels of S1P and C1P were increased in several organs after γ-irradiation or chemotherapy, which indicates an unwanted prometastatic environment related to treatment. Critically, we found that the metastasis of RMS cells in response to S1P can be effectively inhibited in vivo with the S1P-specific binder NOX-S93 that is based on a high-affinity Spiegelmer. These data indicate that bioactive lipids play a vital role in dissemination of RMS and contribute to the unwanted side effects of radio/chemotherapy by creating a prometastatic microenvironment.

摘要

有证据表明,生物活性脂质可能调节生理病理功能,如癌细胞转移。因此,我们确定生物活性脂质化学引诱物鞘氨醇-1-磷酸(S1P)和神经酰胺-1-磷酸(C1P)强烈增强了人横纹肌肉瘤(RMS)细胞的体外迁移和黏附。重要的是,这种作用在两种生物活性脂质的生理浓度下观察到,这两种脂质存在于生物体液中,比观察到的对已知的 RMS 促转移因子如基质衍生因子-1(SDF-1/CXCL12)或肝细胞生长因子/分散因子(HGF/SF)的反应要强得多。我们还提供了新的证据表明,γ辐射或化疗后几种器官中 S1P 和 C1P 的水平增加,这表明与治疗相关的不良促转移环境。关键的是,我们发现,NOX-S93 可以有效地抑制 RMS 细胞对 S1P 的转移,NOX-S93 是一种基于高亲和力 Spiegelmer 的 S1P 特异性结合物。这些数据表明,生物活性脂质在 RMS 的传播中起着至关重要的作用,并通过创造促转移的微环境,导致放射/化学疗法的不良副作用。

相似文献

1
Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy.生物活性脂质 S1P 和 C1P 是人横纹肌肉瘤中的促转移因子,其组织水平会因放射/化疗而升高。
Mol Cancer Res. 2013 Jul;11(7):793-807. doi: 10.1158/1541-7786.MCR-12-0600. Epub 2013 Apr 24.
2
Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapy.生物活性脂质,溶血磷脂酰胆碱(LPC)和溶血磷脂酸(LPA),是新型促转移因子,其组织水平会因放疗/化疗而升高。
Mol Cancer Res. 2014 Nov;12(11):1560-73. doi: 10.1158/1541-7786.MCR-14-0188. Epub 2014 Jul 17.
3
Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.肝细胞生长因子(HGF)和基质细胞衍生因子-1均调节人横纹肌肉瘤细胞的转移行为,但只有HGF能增强其对放化疗的抗性。
Cancer Res. 2003 Nov 15;63(22):7926-35.
4
Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction.生物活性脂质和阳离子抗菌肽作为急性心肌梗死后骨髓源性干细胞归巢的新的潜在调控因子。
Stem Cells Dev. 2013 Jun 1;22(11):1645-56. doi: 10.1089/scd.2012.0488. Epub 2013 Feb 19.
5
Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: a novel role for bioactive lipids and soluble C5b-C9 as homing factors.造血移植的预处理会激活补体级联反应,并在骨髓中诱导产生蛋白水解环境:生物活性脂质和可溶性 C5b-C9 作为归巢因子的新作用。
Leukemia. 2012 Jan;26(1):106-16. doi: 10.1038/leu.2011.185. Epub 2011 Jul 19.
6
Bioactive Phospholipids Enhance Migration and Adhesion of Human Leukemic Cells by Inhibiting Heme Oxygenase 1 (HO-1) and Inducible Nitric Oxygenase Synthase (iNOS) in a p38 MAPK-Dependent Manner.生物活性磷脂通过抑制血红素加氧酶 1(HO-1)和诱导型一氧化氮合酶(iNOS),以依赖 p38 MAPK 的方式增强人白血病细胞的迁移和黏附。
Stem Cell Rev Rep. 2019 Feb;15(1):139-154. doi: 10.1007/s12015-018-9853-6.
7
Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling.鞘氨醇-1-磷酸和神经酰胺-1-磷酸:在细胞信号传导中的作用不断扩展。
J Cell Sci. 2005 Oct 15;118(Pt 20):4605-12. doi: 10.1242/jcs.02637.
8
Sphingosine 1-phosphate stimulates proliferation and migration of satellite cells: role of S1P receptors.鞘氨醇-1-磷酸刺激卫星细胞的增殖和迁移:S1P受体的作用
Biochim Biophys Acta. 2012 Feb;1823(2):439-50. doi: 10.1016/j.bbamcr.2011.11.016. Epub 2011 Dec 8.
9
Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis.一种能结合并中和血管生成的关键介质1-磷酸鞘氨醇的镜像寡核苷酸的鉴定与表征。
Biochem J. 2014 Aug 15;462(1):153-62. doi: 10.1042/BJ20131422.
10
Sphingosine-1-phosphate and ceramide-1-phosphate promote migration, pro-inflammatory and pro-fibrotic responses in retinal pigment epithelium cells.鞘氨醇-1-磷酸和神经酰胺-1-磷酸促进视网膜色素上皮细胞的迁移、促炎和促纤维化反应。
Exp Eye Res. 2022 Nov;224:109222. doi: 10.1016/j.exer.2022.109222. Epub 2022 Aug 27.

引用本文的文献

1
Role of Ceramide Kinase/C1P in the Regulation of Cell Growth and Survival.神经酰胺激酶/C1P在细胞生长和存活调控中的作用
Int J Mol Sci. 2025 Aug 28;26(17):8374. doi: 10.3390/ijms26178374.
2
Sphingosine-1-Phosphate Recruits Macrophages and Microglia and Induces a Pro-Tumorigenic Phenotype That Favors Glioma Progression.鞘氨醇-1-磷酸招募巨噬细胞和小胶质细胞,并诱导一种促进胶质瘤进展的促肿瘤表型。
Cancers (Basel). 2023 Jan 12;15(2):479. doi: 10.3390/cancers15020479.
3
SMPDL3b modulates radiation-induced DNA damage response in renal podocytes.SMPDL3b 调节肾足细胞中辐射诱导的 DNA 损伤反应。
FASEB J. 2022 Oct;36(10):e22545. doi: 10.1096/fj.202100186RR.
4
Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets.鞘脂类在多发性骨髓瘤进展、耐药性中的作用及其作为治疗靶点的潜力
Front Oncol. 2022 Jun 8;12:925807. doi: 10.3389/fonc.2022.925807. eCollection 2022.
5
Vincetoxicum arnottianum modulates motility features and metastatic marker expression in pediatric rhabdomyosarcoma by stabilizing the actin cytoskeleton.鸡屎藤通过稳定肌动蛋白细胞骨架调节儿科横纹肌肉瘤的运动特征和转移标记物的表达。
BMC Complement Med Ther. 2021 May 4;21(1):136. doi: 10.1186/s12906-021-03299-x.
6
Distinctive sphingolipid patterns in chronic multiple sclerosis lesions.慢性多发性硬化病变中独特的神经鞘脂模式。
J Lipid Res. 2020 Nov;61(11):1464-1479. doi: 10.1194/jlr.RA120001022. Epub 2020 Aug 7.
7
Regulation of the amount of ceramide-1-phosphate synthesized in differentiated human podocytes.调控分化人足细胞中神经酰胺-1-磷酸的合成量。
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Dec;1864(12):158517. doi: 10.1016/j.bbalip.2019.158517. Epub 2019 Sep 2.
8
SGPL1 mutation: one main trigger for invasiveness of pediatric alveolar rhabdomyosarcoma.SGPL1 突变:小儿肺泡横纹肌肉瘤侵袭性的主要触发因素之一。
Cancer Gene Ther. 2020 Aug;27(7-8):571-584. doi: 10.1038/s41417-019-0132-8. Epub 2019 Aug 27.
9
Sphingolipids as Emerging Mediators in Retina Degeneration.鞘脂作为视网膜变性中新兴的介质。
Front Cell Neurosci. 2019 Jun 11;13:246. doi: 10.3389/fncel.2019.00246. eCollection 2019.
10
Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor.双重 COX-2/sEH 抑制剂抑制化疗诱导的细胞因子/脂质介质激增和卵巢癌。
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1698-1703. doi: 10.1073/pnas.1803999116. Epub 2019 Jan 15.

本文引用的文献

1
Ceramide-1-phosphate regulates migration of multipotent stromal cells and endothelial progenitor cells--implications for tissue regeneration.神经酰胺-1-磷酸调节多能基质细胞和内皮祖细胞的迁移--对组织再生的影响。
Stem Cells. 2013 Mar;31(3):500-10. doi: 10.1002/stem.1291.
2
Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer.HPV 相关口咽癌放疗或放化疗后远处转移的自然病程。
Oral Oncol. 2013 Jan;49(1):79-85. doi: 10.1016/j.oraloncology.2012.07.015. Epub 2012 Aug 20.
3
Upregulation of heparanase in high-glucose-treated endothelial cells promotes endothelial cell migration and proliferation and correlates with Akt and extracellular-signal-regulated kinase phosphorylation.高糖处理的内皮细胞中乙酰肝素酶的上调促进内皮细胞迁移和增殖,并与Akt和细胞外信号调节激酶磷酸化相关。
Mol Vis. 2012;18:1684-95. Epub 2012 Jun 20.
4
Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesis.靶向癌细跑中的鞘氨醇激酶 1 会通过影响蛋白激酶 C 活性和细胞分裂来减少增殖和存活。
PLoS One. 2012;7(6):e39209. doi: 10.1371/journal.pone.0039209. Epub 2012 Jun 25.
5
S1P2 receptor promotes mouse skeletal muscle regeneration.S1P2 受体促进小鼠骨骼肌再生。
J Appl Physiol (1985). 2012 Sep 1;113(5):707-13. doi: 10.1152/japplphysiol.00300.2012. Epub 2012 Jun 28.
6
Neural cell adhesion molecule modulates mesenchymal stromal cell migration via activation of MAPK/ERK signaling.神经细胞黏附分子通过激活 MAPK/ERK 信号通路调节间充质基质细胞迁移。
Exp Cell Res. 2012 Oct 15;318(17):2257-67. doi: 10.1016/j.yexcr.2012.05.029. Epub 2012 Jun 5.
7
Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis.环磷酰胺为前列腺癌骨转移创造了一个易感性的微环境。
Cancer Res. 2012 May 15;72(10):2522-32. doi: 10.1158/0008-5472.CAN-11-2928.
8
Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells.鞘氨醇-1-磷酸受体-3 信号上调表皮生长因子受体并增强培养的肺腺癌细胞中表皮生长因子受体介导的致癌活性。
Int J Oncol. 2012 May;40(5):1619-26. doi: 10.3892/ijo.2012.1379. Epub 2012 Feb 16.
9
Sphingosine 1-phosphate stimulates proliferation and migration of satellite cells: role of S1P receptors.鞘氨醇-1-磷酸刺激卫星细胞的增殖和迁移:S1P受体的作用
Biochim Biophys Acta. 2012 Feb;1823(2):439-50. doi: 10.1016/j.bbamcr.2011.11.016. Epub 2011 Dec 8.
10
Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma.鞘氨醇激酶 1 通过 S1P/EDG1 轴促进肝癌细胞迁移和侵袭。
Liver Int. 2012 Feb;32(2):331-8. doi: 10.1111/j.1478-3231.2011.02666.x. Epub 2011 Oct 30.